eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
3/2024
vol. 20
 
Share:
Send email
Share:
Original paper

A new and easy parameter to predict the requirement for permanent pacemaker implantation after transaortic valve implantation: aortic knob calcification

Ahmet Özderya
1
,
Murat G. Yerlikaya
2
,
Ahmet O. Aslan
2
,
Ali H. Konuş
3
,
Sinan Şahin
4
,
Hatice A. A. Korkmaz
5
,
Muhammet R. Sayın
2
,
Ali R. Akyüz
2

  1. Cardiology Clinic, Trabzon Kanuni Training and Research Hospital, Trabzon, Turkey
  2. Department of Cardiology, University of Health Sciences, Trabzon Ahi Evren Cardiovascular and Thoracic Surgery Training and Research Hospital, Trabzon, Turkey
  3. Department of Cardiology, Bingol State Hospital, Bingöl, Turkey
  4. Department of Cardiology, Şişli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, İstanbul, Turkey
  5. Radiology Clinic, Trabzon Kanuni Training and Research Hospital, Trabzon, Turkey
Adv Interv Cardiol 2024; 20, 3 (77): 319–328
DOI: https://doi.org/10.5114/aic.2024.142236
Online publish date: 2024/08/13
Article file
- a new and easy.pdf  [0.16 MB]
Get citation
 
 
1. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992; 13: 704-8.
2. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106: 3006-8.
3. Popma JJ, Adams DH, Reardon MJ, et al.; CoreValve United States Clinical Investigators. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 2014; 63: 1972-81.
4. Van Mieghem NM, Reardon MJ, Yakubov SJ, et al. Clinical outcomes of TAVI or SAVR in men and women with aortic stenosis at intermediate operative risk: a post hoc analysis of the randomised SURTAVI trial. EuroIntervention 2020; 16: 833-41.
5. Jørgensen TH, Thyregod HGH, Ihlemann N, et al. Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J 2021; 42: 2912-9.
6. Sinclair N, Mordhorst A, Yang GK, et al. Vascular access complications and clinical outcomes of vascular surgical repairs following transcatheter aortic valve implantation (TAVI). Ann Vasc Surg 2021; 74: 258-63.
7. Wischmann P, Stern M, Baasen S, et al. Importance of pseudoaneurysms after TAVI – a retrospective analysis of 2063 patients. Vasa 2024 Jul 17. doi: 10.1024/0301-1526/a001135.
8. Jørgensen TH, Thyregod HGH, Ihlemann N, et al. Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J 2021; 42: 2912-9.
9. Nazif TM, Williams MR, Hahn RT, et al. Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J 2014; 35: 1599-607.
10. Mangieri A, Montalto C, Pagnesi M, et al. TAVI and post procedural cardiac conduction abnormalities. Front Cardiovasc Med 2018; 5: 85.
11. van der Boon RM, Nuis RJ, Van Mieghem NM, et al. New conduction abnormalities after TAVI--frequency and causes. Nat Rev Cardiol 2012; 9: 454-63.
12. Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2021; 42: 3427-520.
13. Abramowitz Y, Kazuno Y, Chakravarty T, et al. Concomitant mitral annular calcification and severe aortic stenosis: prevalence, characteristics and outcome following transcatheter aortic valve replacement. Eur Heart J 2017; 38: 1194-203.
14. Giustino G, Van der Boon RM, Molina-Martin de Nicolas J, et al. Impact of permanent pacemaker on mortality after transcatheter aortic valve implantation: the PRAGMATIC (Pooled Rotterdam-Milan-Toulouse in Collaboration) Pacemaker substudy. EuroIntervention 2016; 12: 1185-93.
15. Mauri V, Reimann A, Stern D, et al. Predictors of permanent pacemaker implantation after transcatheter aortic valve replacement with the SAPIEN 3. JACC Cardiovasc Interv 2016; 9: 2200-9.
16. De Carlo M, Giannini C, Bedogni F, et al. Safety of a conservative strategy of permanent pacemaker implantation after transcatheter aortic CoreValve implantation. Am Heart J 2012; 163: 492-9.
17. Ledwoch J, Franke J, Gerckens U, et al. Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation: analysis from the German transcatheter aortic valve interventions registry. Catheter Cardiovasc Interv 2013; 82: E569-77.
18. Allison MA, Cheung P, Criqui MH, et al. Mitral and aortic annular calcification are highly associated with systemic calcified atherosclerosis. Circulation 2006; 113: 861-6.
19. Toggweiler S, Kobza R. Pacemaker implantation after transcatheter aortic valve: why is this still happening? J Thorac Dis 2018; 10 (Suppl 30): S3614-9.
20. Adar A, Onalan O, Cakan F, et al. Aortic arch calcification on routine chest radiography is strongly and independently associated with non-dipper blood pressure pattern. Arq Bras Cardiol 2020; 114: 109-17.
21. Szotek M, Drużbicki Ł, Sabatowski K, et al. Transcatheter aortic valve implantation and cardiac conduction abnormalities: prevalence, risk factors and management. J Clin Med 2023; 12: 6056.
22. Sá MP, Van den Eynde J, Malin JH, et al. Impact of left ventricle outflow tract calcification on the outcomes of transcatheter aortic valve implantation: a study-level meta-analysis. J Card Surg 2022; 37: 1379-90.
23. Sharma E, McCauley B, Ghosalkar DS, et al. Aortic valve calcification as a predictor of post-transcatheter aortic valve replacement pacemaker dependence. Cardiol Res 2020; 11: 155-67.
24. Mahajan S, Gupta R, Malik AH, et al. Predictors of permanent pacemaker insertion after TAVR: a systematic review and updated meta-analysis. J Cardiovasc Electrophysiol 2021; 32: 1411-20.
25. Husser O, Pellegrini C, Kessler T, et al. Predictors of permanent pacemaker implantations and new-onset conduction abnormalities with the SAPIEN 3 balloon- expandable transcatheter heart valve. JACC Cardiovasc Interv 2016; 9: 244-54.
26. Rubín JM, Avanzas P, del Valle R, et al. Atrioventricular conduction disturbance characterization in transcatheter aortic valve implantation with the CoreValve prosthesis. Circ Cardiovasc Interv 2011; 4: 280-6.
27. Hokken TW, Muhemin M, Okuno T, et al. Impact of membranous septum length on pacemaker need with different transcatheter aortic valve replacement systems: the INTERSECT registry. J Cardiovasc Comput Tomogr 2022; 16: 524-30.
28. Gama F, Gonçalves PA, Abecasis J, et al. Predictors of pacemaker implantation after TAVI in a registry including self, balloon and mechanical expandable valves. Int J Cardiovasc Imaging 2022; 38: 225-35.
29. Ravaux JM, Van Kuijk SMJ, Di Mauro M, et al. Incidence and predictors of permanent pacemaker implantation after transcatheter aortic valve procedures: data of the Netherlands Heart Registration (NHR). J Clin Med 2022; 11: 560.
30. Symeonidis G, Papanas N, Giannakis I, et al. Gravity of aortic arch calcification as evaluated in adult Greek patients. Int Angiol 2002; 21: 233-6.
31. Tian WB, Zhang WS, Jiang CQ, et al. Aortic arch calcification and risk of all-cause mortality and cardiovascular disease: the Guangzhou Biobank Cohort Study. Lancet Reg Health West Pac 2022; 23: 100460.
32. Korkmaz L, Adar A, Ata Korkmaz A, et al. Aortic knob calcification and coronary artery lesion complexity in non-ST-segment elevation acute coronary syndrome patients. Turk Kardiyol Dern Ars 2012; 40: 606-11.
33. Korkmaz A, Akyüz AR. Aortic knob calcification and cardio ankle vascular index in asymptomatic hypertensive patients. Blood Press Monit 2017; 22: 8-11.
34. Costa G, Criscione E, Reddavid C, et al. Balloon-expandable versus self- expanding transcatheter aortic valve replacement: a comparison and evaluation of current findings. Expert Rev Cardiovasc Ther 2020; 18: 697-708.
35. Kodali S, Thourani VH, White J, et al. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J 2016; 37: 2252-62.
36. Schymik G, Lefèvre T, Bartorelli AL, et al. European experience with the second- generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry. JACC Cardiovasc Interv 2015; 8: 657-69.
37. Delgado-Arana JR, Gordillo-Monge MX, Halim J, et al. Early clinical and haemodynamic matched comparison of balloon-expandable valves. Heart 2022; 108: 725-32.
38. Akyüz AR, Konuş AH, Çırakoğlu ÖF, et al. First experiences with a new balloon-expandable Myval transcatheter aortic valve: a preliminary study. Erste Erfahrungen mit einer neuen ballon expandierbaren Myval-Transkatheter- Aortenklappe: eine vorläufige Studie. Herz 2022; 47: 449-55.
39. Barki M, Ielasi A, Buono A, et al. Clinical comparison of a novel balloon-expandable versus a self-expanding transcatheter heart valve for the treatment of patients with severe aortic valve stenosis: the EVAL Registry. J Clin Med 2022; 11: 959.
40. Kilic T, Ielasi A, Ninios V, et al. Clinical outcomes of the Myval transcatheter heart valve system in patients with severe aortic valve stenosis: a two-year follow-up observational study. Arch Med Sci 2024; 20: 410-9.
41. Xu S, Zhang E, Qian Z, et al. Mid- to long-term clinical and echocardiographic effects of post-procedural permanent pacemaker implantation after transcatheter aortic valve replacement: a systematic review and meta-analysis. Front Cardiovasc Med 2022; 9: 911234.
42. Engborg J, Riechel-Sarup C, Gerke O, et al. Effect of permanent pacemaker on mortality after transcatheter aortic valve replacement. Scand Cardiovasc J 2017; 51: 40-6.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.